Farmacological Treatment for Patients with Hypertension, Stable Angina, Dyslipidemia, and Risk Factors

Medications for Cardiovascular Prevention

The American College of Cardiology recommends aspirin 75-150 mg daily as first-line treatment to prevent cardiovascular events in patients with established coronary artery disease 1
The American Heart Association suggests clopidogrel 75 mg daily as an alternative in case of aspirin intolerance 1, 2
The American College of Cardiology recommends beta blockers as first-line treatment for hypertension in patients with stable angina 3
The American Heart Association recommends metoprolol 50-100 mg twice daily or atenolol 50-100 mg daily, preferring cardioselective beta blockers without intrinsic sympathomimetic activity 1, 3
The American College of Cardiology recommends ACE inhibitors as additional treatment 1, 4
The American Heart Association suggests ramipril 10 mg daily or perindopril 8 mg daily for additional vascular protection 1, 4
The American Heart Association recommends a blood pressure target of <130/80 mmHg due to the presence of diabetes, coronary artery disease, and multiple risk factors 3

The American College of Cardiology recommends high-intensity statins as the basis of treatment 2, 5
The American Heart Association suggests atorvastatin 40-80 mg daily or rosuvastatin 20-40 mg daily 5, 6
The American College of Cardiology recommends a target LDL cholesterol level of <100 mg/dL (ideally <70 mg/dL) 5

The American College of Cardiology recommends sublingual nitroglycerin 0.4 mg for immediate relief of angina episodes 1, 7
The American Heart Association suggests instructing patients to take a dose if they experience chest pain, which can be repeated up to 3 doses with 5-minute intervals 7

The American Heart Association recommends implementing counseling for smoking cessation using the 5 A's approach (Ask, Advise, Analyze, Assist, Arrange) 8
The American College of Cardiology recommends offering pharmacological therapy for smoking cessation 8
The American Heart Association suggests varenicline starting with 0.5 mg daily for 3 days, increasing to 0.5 mg twice daily for 4 days, then 1 mg twice daily for 12 weeks 8

The American Diabetes Association recommends metformin as first-line treatment for glucose control in patients with overweight and probable diabetes (HbA1c 7.6%) 2
The American Heart Association suggests initiating metformin with 500 mg daily, gradually increasing to 1000 mg twice daily as tolerated 2
The American Diabetes Association recommends a target HbA1c level of <7% considering the patient's age and comorbidities 2

The American College of Cardiology recommends monitoring renal function and electrolytes when initiating ACE inhibitor therapy 1
The American Heart Association suggests evaluating adherence to treatment at each visit, as it is crucial for therapeutic success 7

The American College of Cardiology recommends monitoring lipid profiles at 4-6 weeks after initiating lipid-lowering treatment 5
The American Heart Association suggests monitoring blood pressure every 2-4 weeks until the target is reached 3
The American College of Cardiology recommends evaluating angina symptoms and adjusting anti-ischemic medication as needed 1
The American Heart Association suggests considering a stress test to evaluate the effectiveness of anti-ischemic treatment 1

The American Diabetes Association recommends continuing metformin at 1000 mg twice daily as it remains the first-line treatment for diabetes and has cardiovascular benefits 9
Metformin can be safely continued in patients with stable coronary artery disease, according to the American Diabetes Association 10
The American College of Cardiology recommends targeting LDL-cholesterol level should be <70 mg/dL for this high-risk patient with established cardiovascular disease 11
Consider adding ezetimibe if LDL goals are not achieved with maximum tolerated dose of atorvastatin, as suggested by the European Society of Cardiology 12
The American Heart Association strongly recommends ACE inhibitors, such as ramipril, in patients with diabetes, hypertension, and coronary artery disease 11, 13
Target blood pressure should be <130/80 mmHg due to the presence of diabetes and cardiovascular disease, according to the American Heart Association 13

The American College of Cardiology recommends adding a beta-blocker as first-line anti-anginal therapy, such as metoprolol 50-100 mg twice daily or atenolol 50-100 mg daily 14
Beta-blockers reduce cardiac events and are strongly recommended as initial therapy for chronic stable angina, according to the American College of Cardiology 15, 16
The American Heart Association recommends adding aspirin 75-150 mg daily as it should be used routinely in all patients with coronary artery disease 15

The American Heart Association recommends implementing a Mediterranean or DASH diet pattern with reduced saturated fat and increased consumption of vegetables, fruits, and fish 14, 17
Regular physical activity within the patient's limitations can improve exercise tolerance and reduce symptoms, according to the European Society of Cardiology 17

Consider proton pump inhibitor therapy if the patient is at high risk of gastrointestinal bleeding with the addition of aspirin, as suggested by the European Society of Cardiology 12
The American Diabetes Association recommends considering exercise ECG testing or pharmacologic stress testing to evaluate the severity of coronary artery disease 10
Coronary artery calcium measurement may be reasonable for cardiovascular risk assessment in this patient, according to the American Diabetes Association 10